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Abstract
Background: Evidence on longitudinal associations between smoking and frailty is scarce. The objective of this
study was to systematically review the literature on smoking as a predictor of frailty changes among community-
dwelling middle-aged and older population.
Methods: A systematic search was performed using three electronic databases: MEDLINE, Embase and Scopus for
studies published from 2000 through May 2015. Reference lists of relevant articles, articles shown as related
citations in PubMed and articles citing the included studies in Google Scholar were also reviewed. Studies were
included if they were prospective observational studies investigating smoking status as a predictor and subsequent
changes in frailty, defined by validated criteria among community-dwelling general population aged 50 or older.
A standardised data collection tool was used to extract data. Methodological quality was examined using the
Newcastle-Ottawa Scale for cohort studies.
Results: A total of 1020 studies were identified and systematically reviewed for their titles, abstracts and full-text to
assess their eligibilities. Five studies met inclusion criteria and were included in this review. These studies were
critically reviewed and assessed for validity of their findings. Despite different methodologies and frailty criteria
used, four of the five studies consistently showed baseline smoking was significantly associated with developing
frailty or worsening frailty status at follow-up. Although not significant, the other study showed the same trend in
male smokers. It is of note that most of the estimate measures were either unadjusted or only adjusted for a
limited number of important covariates.
Conclusions: This systematic review provides the evidence of smoking as a predictor of worsening frailty status in
community-dwelling population. Smoking cessation may potentially be beneficial for preventing or reversing frailty.
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Background
Frailty is a multidimensional geriatric syndrome char-
acterised by decreased physiological reserves and in-
creased vulnerability to adverse health outcomes due
to age-related accumulation of multisystem deficits
and impaired capacity to maintain homeostasis [1–3].
The adverse outcomes include dependency, falls, hos-
pitalisation, institutionalisation and death [2–4]. Al-
though no consensus on a definition of frailty has
been reached, the most common description used to
operationalise frailty is phenotype criteria proposed by
Fried et al. in the Cardiovascular Health Study, the
United States [5]. In the study, frailty was defined as
having three or more of the following five physical
components: unintentional weight loss, self-reported
exhaustion, weakness, slow walking speed and low
physical activity [5]. Another frequently used ap-
proach is the frailty index, a model of accumulated
health deficits, which can be constructed based on
diseases, symptoms, signs or disabilities [6]. There
have been further alternative measurements of frailty
proposed in the literature [7], including a range of
newer brief measures designed to be used in clinical
practice such as FRAIL scale [8] or Edmonton Frail
Scale [9].
Smoking is an important modifiable lifestyle factor and
has been examined in population-based studies on
* Correspondence: gotarokojima@yahoo.co.jp
Department of Primary Care and Population Health, University College
London (Royal Free Campus), Rowland Hill Street, London NW3 2PF, UK
© 2015 Kojima et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kojima et al. BMC Geriatrics  (2015) 15:131 
DOI 10.1186/s12877-015-0134-9
frailty. However in many studies, smoking has been used
for adjustment as a confounding covariate to examine
independent risks of target outcomes, and only a limited
number of studies have focused on associations between
smoking and frailty. Given that tobacco use is a major
cause of preventable death and is associated with various
negative health outcomes [10, 11], it is hypothesised that
smokers are more likely to be frail than non-smokers.
Unexpectedly, however, cross-sectional studies show
mixed results and in some studies, smoking is associated
with being less frail [12–15]. A large European study
showed cross-sectional associations between smoking
and frailty by age groups [12]. In those in their 50’s
current smoking status was positively associated with
frailty but negatively associated with frailty for those in
their 70’s [15]. In light of higher morbidity and mortality
risks in smokers, these paradoxical findings may have re-
sulted from the survivor effect; frail smokers having died
early or becoming too frail to smoke, therefore smoking
habit as a contributor to frailty may diminish in the very
old. In any case, a cross-sectional study design does not
allow causal relationships to be inferred and prospective
observational studies appropriately controlling for con-
founding factors are required to assess the causality.
There has been one systematic review paper on the as-
sociation between frailty and various health-related and
socio-demographic factors including smoking [16]. Al-
though ten articles examining smoking and frailty were
identified, most of them had a cross-sectional study de-
sign and only two articles longitudinally examined smok-
ing as a predictor of frailty changes in the general
population [17, 18]. In addition, the review was limited
to only studies using Fried phenotype criteria and did
not include other important studies using different
criteria.
The objective of the current study was to systematic-
ally review the literature for evidence on smoking as a
predictor of subsequent frailty status changes in longitu-
dinal studies among the general population.
Methods
Data sources and search strategy
This systematic review was conducted according to a
protocol developed with adherence to Preferred Report-
ing Items for Systematic Review and Meta-Analyses
(PRISMA) statement [19]. One investigator (GK) per-
formed a systematic search of the literature in May 2015
using MEDLINE, Embase and Scopus without language
restriction using an explosion function and Medical Sub-
ject Heading terms if available from 2000 through
current. Validated definitions of frailty were not gener-
ally used prior to 2000, and the two most widely ac-
cepted definitions and measurements for frailty, the
frailty phenotype [5] and the frailty index [6] were first
published in 2001. The search terms included (“Smok-
ing” OR “Smoking cessation” OR “Smoking cessation
program” OR “Smoking habit” OR “Tobacco” OR
“Smokeless Tobacco” OR “Tobacco products” OR “To-
bacco consumption” OR “Tobacco dependence” OR
“Tobacco smoker” OR “Nicotine” OR “Nicotine deriva-
tive” OR “Nicotine gum” OR “Nicotine lozenge” OR
“Nicotine Patch” OR “Nicotine replacement therapy” OR
“Cotinine” OR “Smok*” OR “Tobacc*” OR “Nicotin*”
OR “Cotinin*” OR “Cigarett*”) AND “Frail*”. Additional
sources included reference lists of relevant articles, arti-
cles shown as related citations in PubMed of the in-
cluded studies and articles citing the included studies
displayed under Cited by in Google Scholar.
Study selection and data extraction
Studies were considered to be potentially eligible for in-
clusion if they were prospective observational studies in-
vestigating smoking status as a predictor and subsequent
frailty status as an outcome among the community-
dwelling general population aged 50 or older. In
addition, in order to be considered for inclusion, frailty
must have been defined criteria originally designed to
measure frailty and validated in population-based studies
or its modified versions, such as Fried phenotype criteria
or the frailty index [5, 6]. Studies were excluded if they
substituted other measures, such as disability or nursing
home placement [20], to define frailty or used selected
samples with certain diseases or conditions [21]. All po-
tentially eligible studies identified were searched for du-
plicates using the Endnote duplicate finding function
and manually, followed by title, abstract and full-text re-
views. A standardised data collection tool was used to
collect data from the eligible studies.
Methodological quality assessment
Methodological quality of the eligible studies were exam-
ined using the Newcastle-Ottawa Scale for cohort stud-
ies [22]. This scale has nine criteria to examine the
methodological quality of cohort studies. Each of the in-
cluded studies was assessed using this scale and consid-
ered to have adequate quality if it met five or more of
the nine items.
Data analysis
It was planned to perform meta-analysis to synthesise
pooled estimates from the included studies if possible,
otherwise a narrative review would be pursued.
Results
Selection processes
A PRISMA flowchart [19] of the literature search and
study selection with the number of studies at each stage
is presented in Fig. 1. Of the 1020 citations identified
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from the literature search using three electronic data-
bases and other sources, 536 duplicated studies were ex-
cluded, and 431 and 41 studies were also excluded
through title and abstract review, respectively, leaving 12
studies for potential inclusion. Full-texts of these 12
studies were assessed and seven studies were further ex-
cluded because smoking status was not used as a predictor
(n = 3), study designs were cross-sectional (n = 2), a se-
lected population was used (n = 1) or non-validated frailty
criteria were used (n = 1). Five studies [17, 18, 23–25] were
confirmed to meet the inclusion criteria and were in-
cluded in this systematic review.
Study characteristics
Characteristics of the five studies are summarised in
Table 1. Two studies were from the US [17, 18] and
China [23, 24], respectively, and one study used popula-
tions from 11 European countries [25]. The largest study
involved 28,181 women from the Women’s Health Ini-
tiative Observational Study [18]. The other studies used
cohorts consisting of almost half men and half women
[17, 23–25]. Three studies defined three smoking status
categories: ‘never’, ‘past’ and ‘current’ smoking [18, 24, 25]
and two studies defined two categories: ‘never/past’ versus
‘current’ smoking [17] and ‘never’ versus ‘past/current
smoking’ [23], respectively. Four studies used the Fried
phenotype frailty criteria [17, 18, 24, 25]; one study used
the frailty index [23]. Although only two kinds of criteria
were used, measures of changes in frailty status as out-
comes at follow-up varied across the included studies. The
follow-up periods ranged widely from two years to
15 years. In terms of statistical analysis, three studies used
logistic regression models [18, 24, 25] and two studies
used linear regression models [17, 23]. Four studies con-
ducted multivariate regression models controlling for at
least age and gender [17, 23–25], which are important
confounding factors for both smoking and frailty, and one
study showed only the results of unadjusted models [18].
The included studies were assessed for methodological
quality using the Newcastle-Ottawa quality assessment
scale for cohort studies. All five studies met at least five
criteria and were considered to have adequate methodo-
logical quality (Table 2).
Etman et al. investigated associations between smoking
status (never, former and current) at baseline and frailty
status at two-year follow-up using a large cohort of
14,082 middle-aged and older community-dwelling men
and women from the Survey on Health, Ageing, and
Fig. 1 PRISMA Flowchart
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Table 1 Summary of included studies on smoking associated with subsequent frailty status change among community-dwelling older people
Author, year Location N Age* Female
(%)
Smoking
definition
Frailty outcome Follow-
up
Finding
Woods et al.,
2005 [18]
USA 28,181 65–79 100 % never, past,
current
smoking
Incident frailty by
modified Fried criteria
3 years - Past smoking was associated with incident frailty (OR = 1.12 95 %
CI = 1.02–1.23), but not prefrailty (OR = 0.95 95 % CI = 0.89–1.02).
- Current smoking was associated with both incidence frailty (OR = 1.76 95 %
CI = 1.49–2.09) and prefrailty (OR = 2.90 95 % CI = 2.35–3.57)
- Unadjusted multinomial logistic regression.
Ottenbacher
et al., 2009 [17]
USA 777 82.5 56.4 % never, past,
current
smoking
Fried frailty score
(range: 0–5)
10 years - “Ever smoked” was associated with increase in frailty score at follow-up
(beta = 0.36, SE = 0.15, p < 0.05)
- Linear regression adjusted for age, gender, education, married, financial strain, diabetes,
hip fracture, cancer, stroke, cardiac diseases, arthritis, body mass index and baseline frailty.
Wang et al.,
2013 [23]
China 3257 70.1 51.1 % never,
current/past
smoking
Frailty index 15 years - Current/past smoking was associated with increase in frailty at follow-up
(beta = 3.64, SE = 1.62, p = 0.03) in men.
- No such association was observed in women.
- Linear regression adjusted for age, education, baseline frailty index.
Lee et al.,
2014 [24]
China 3018 73.6 49.7 % never, past,
current
smoking
Change in frailty Category
change by Fried criteria
2 years - No significant association was observed.
- Gender-stratified age-adjusted logistic regression
Etman et al.,
2015 [25]
11 European
countries
14,082 >55 54.3 % never, past,
current
smoking
Worsening in frailty by
Fried criteria (robust >
prefrail/frail
or prefrail > frail)
2 years - Current smoking was associated with worsening of frailty status at follow-up (OR = 1.16,
95 % CI = 1.02–1.32, p < 0.05)
- Logistic regression adjusted for age, gender, education, baseline frailty and country.
*Mean age, age range, or age for inclusion
95 % CI: 95 % confidence interval, OR: Odds ratio, SE: Standard error
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Retirement in Europe (SHARE) [25]. Using modified
Fried phenotype criteria (either from robust to prefrail/
frail or from prefrail to frail), the authors showed that
current smokers had a 16 % increased risk of worsening
frailty status two years after baseline, compared to those
who never smoked; multivariate logistic regression
models were adjusted for age, gender, educational level,
baseline frailty state and country (OR = 1.16, 95 % CI =
1.02–1.32, p < 0.05).
In the Hispanic Established Populations for Epidemio-
logic Studies of the Elderly (EPESE), among 777 His-
panic Americans aged 65 or older, those who ever
smoked were significantly more likely to have a higher
frailty status at follow-up than those who never smoked
[17]. In this study, a summary frailty score, defined as
the total number of five components of Fried phenotype
criteria ranging from 0 to 5, was created and used as a
continuous variable in multivariate linear regression
models adjusted for age, gender, body mass index, edu-
cation, marital status, financial strain, chronic diseases
and baseline frailty score to examine frailty status
changes over 10 years (unstandardised coefficient = 0.36,
standard error = 0.15, p < 0.05).
A Chinese study of 3018 community-dwelling older
people examining changes in frailty status over two years
according to smoking status is the only study that failed
to show significant findings [24]. Although not reaching
statistical significance, directions of the associations be-
tween smoking and frailty appear consistent with the
other included studies in that frailty status of (male)
current smokers were more likely to worsen and less
likely to improve than it was for those who never
smoked in age-adjusted logistic regression models
(OR = 1.53, 95 % CI = 0.73–3.23 for prefrail worsening;
OR = 1.29, 95 % = 0.75–2.23 for robust worsening; OR =
0.63, 95 % = 0.33–1.21 for prefrail improvement; OR =
0.21, 95 % = 0.02–1.80 for frail improvement). No trends
were observed among women. There is a possibility that
the statistical power may have been lost as a result of div-
iding the cohort by gender and further by three Fried
frailty categories (robust, prefrail and frail) at baseline as
well as using three smoking statuses as predictors (never,
past and current) and using four different frailty transition
states (prefrail worsening, prefrail improvement, robust
worsening and frail improvement).
A US study involving 28,181 women aged 65 to 79
from the Women’s Health Initiative Observational Study
who were free from frailty at baseline examined risk of
newly developing frailty and prefrailty with modified
Fried phenotype criteria over three years according to
baseline smoking status and using unadjusted multi-
nomial logistic regression models [18]. Past smoking
predicted incident frailty (OR = 1.12, 95 % = 1.02–1.23),
but not prefrailty (OR = 0.95, 95 % CI = 0.89–1.02), and
current smoking predicted incident frailty (OR = 2.90,
95 % CI = 2.35–3.57) and prefrailty (OR = 1.76, 95 %
CI = 1.49–2.09). The findings of this study need to be
interpreted cautiously because important confounding
factors including age, socioeconomic status, education
and alcohol use, were not controlled for in the
models.
Only one study employed a frailty index and assessed
frailty status among 3257 Chinese community-dwellers
aged ≥ 55. Men and women were analysed separately
using multivariate linear regression models adjusted for
age, education and baseline frailty index [23]. Current
and past male smokers showed a worsening in their
frailty status over the 15-year follow-up, significantly
more than men who never smoked (standardised coeffi-
cient = 3.643, standard error = 1.621, p = 0.026) while
there was no such difference observed in women (p =
0.529). In this study, the frailty index was constructed
based on 28 variables excluding respiratory health defi-
cits such as chronic tracheitis or cough, which are dir-
ectly related to smoking. The analyses were also
repeated with a frailty index using 25 variables without
three non-respiratory smoking-related variables (hyper-
tension, cardiovascular disease and cerebrovascular dis-
ease), providing similar results.
Most studies demonstrated current, past (or both)
smoking status at baseline predicted subsequent incident
or worsening of frailty status at follow-up [17, 18, 23,
Table 2 Methodological quality assessment using the Newcastle-Ottawa Quality Assessment Scale for cohort studies
Author Selection 1 Selection 2 Selection 3 Selection 4 Comparability 1 Comparability 2 Outcome 1 Outcome 2 Outcome 3 Total
Woods et al.,
2005 [18]
1 1 0 1 0 0 1 1 0 5/9
Ottenbacher
et al., 2009 [17]
1 1 0 n/a 1 1 1 1 0 6/8
Wang et al.,
2013 [23]
1 1 0 n/a 1 1 1 1 0 6/8
Lee et al.,
2014 [24]
1 1 0 n/a 1 0 1 1 0 5/8
Etman et al.,
2015 [25]
1 1 0 n/a 1 1 1 1 0 6/8
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25]. One study failed to show any significant associations
between baseline smoking status and frailty trajectories
[24]. It is of note however that most of the estimate
measures were either unadjusted or only adjusted for a
limited number of important covariates. We were unable
to perform a meta-analysis due to methodological diver-
sity of the included studies.
Discussion
This systematic review identified five prospective cohort
studies on smoking and frailty. Although the studies
employed different methodology and frailty criteria,
most studies demonstrated that baseline smoking signifi-
cantly predicted worsening of frailty status at follow-up.
All studies at best only adjusted for a very limited range
of potential confounding factors.
The association between smoking and subsequently
developing or worsening frailty demonstrated by the in-
cluded studies suggests that smoking may play a role in
the pathogenesis of frailty. The underlying mechanism
by which smokers are predisposed to frailty is not clear
but is likely to be multifactorial given the detrimental ef-
fects of smoking on a wide range of organs and tissues
[11]. Smoking is associated with cardiovascular diseases,
respiratory diseases and cancers [11], all of which could
cause morbidities and disabilities (both physical and
mental), and potentially contribute to increased risks of
frailty status.
The association between smoking and frailty may be
explained by inflammation. Cigarette smoke contains
various toxic chemicals and has been shown to be asso-
ciated with increased levels of various inflammatory me-
diators [26]. Chronic inflammation causes muscle
wasting [27] and leads to weight loss, exhaustion, weak-
ness or slow gait speed; these are all major components
of frailty [5]. This possible link between smoking and
frailty via inflammation is further supported by
population-based studies reporting that elevated inflam-
matory markers were associated with a higher preva-
lence and incidence of frailty [28–30].
The current systematic review has some limitations.
First, the systematic literature search, study selection,
data extraction and methodological quality assessment
were conducted by one researcher; involving at least two
researchers would have been more appropriate. Second,
a relatively limited number of studies were identified,
and some studies may have been missed that were not
referenced on the three main data sources searched.
Nonetheless, four out of the five included studies con-
sistently showed evidence that smoking was a predictor
of frailty status. Third, partly because a uniform defin-
ition of frailty has not yet been identified, study designs
and methodologies of the included studies varied widely
therefore meta-analysis was not possible.
“Currently smokers” can range from a person who
smokes a few cigarettes a day to a person who has been
smoking two packs per day for five decades, and “former
smokers” can be a fit person who temporarily smoked
when he/she was a teenager or can be a frail person who
had to quit smoking recently because of severe emphy-
sema due to life-long heavy smoking. All of the included
studies examined only current status of smoking, how-
ever the amount of smoking history, such as by pack-
years, is an important factor to examine impacts of
smoking, and none of the studies in this review exam-
ined this. Therefore, the magnitude of the contribution
of smoking to the development of frailty was not clear
from the evidence identified by the current review. One
study cross-sectionally investigated severity of frailty
across three groups created based on amount and length
of smoking history: 1) heavy smokers defined as one
pack a day for 20 years or more, 2) light smokers defined
as less than one pack a day or 1 pack per day for less
than 20 years and 3) never smokers, and showed a dose-
response association between smoking and frailty: heavy
smokers had the highest degree of frailty and never
smoker the lowest [15].
Although some of the included studies were not ori-
ginally designed to examine the associations between
smoking and frailty, it is important to note that some
studies did not adjust or only adjusted for a limited
number of confounding factors [18, 24, 25]. The import-
ant variables which should be considered for the link be-
tween smoking and frailty may include but not limited
to age, gender, education, socioeconomic status and al-
cohol use.
In the future research, therefore, detailed smoking his-
tory information in addition to current smoking status,
rather than just current, past and never smoking, and
controlling for the abovementioned confounding vari-
ables should be taken into account to enable more ac-
curate analysis and to provide more relevant results on
the association between smoking and frailty.
Conclusion
In summary, this systematic review provides evidence
suggesting smoking can be a predictor of worsening
frailty status among community-dwelling people. Smok-
ing cessation may potentially be beneficial for preventing
or reversing frailty.
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